Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.zotahealthcare.com | |
Market Cap | 694.43 Cr. | |
Enterprise Value(EV) | 692.14 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -1.65 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 34.38 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 8.03 | Calculated using Price: 276.00 |
Dividend Yield | 0.54 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.52 Cr. | 25,160,327 Shares |
FaceValue | 10 | |
About Zota Health Care Ltd. | ||
Zota Health Care manufactures and markets pharmaceutical formulations, nutraceutical, and ayurvedic medicines in India and internationally. They mainly market generic, patented and OTC pharmaceutical products. Products are marketed in the form of tablets, capsules, ointment, oral liquids, injectable etc as per customers need. |
1 Day |
|
+0.04% |
1 Week |
|
-0.77% |
1 Month |
|
-1.09% |
3 Month |
|
-11.81% |
6 Month |
|
+3.14% |
1 Year |
|
+3.47% |
2 Year |
|
+84.86% |
5 Year |
|
+86.75% |
10 Year |
|
4 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 8.05 | 3.98 | -0.31 | 11.43 | |
Return on Capital Employed (%) | 11.45 | 5.71 | -0.38 | 16.36 | |
Return on Assets (%) | 6.19 | 3.08 | -0.24 | 7.94 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 69 | 69 | 66 | 90 | 86 | |
Non Curr. Liab. | 1 | 1 | 1 | 13 | 32 | |
Curr. Liab. | 20 | 19 | 18 | 36 | 39 | |
Minority Int. | ||||||
Equity & Liab. | 90 | 88 | 85 | 139 | 157 | |
Non Curr. Assets | 27 | 30 | 24 | 62 | 75 | |
Curr. Assets | 62 | 59 | 61 | 77 | 82 | |
Misc. Exp. not W/O | ||||||
Total Assets | 90 | 88 | 85 | 139 | 157 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 86 | 95 | 107 | 131 | 134 | |
Other Income | 2 | 2 | 1 | 2 | 3 | |
Total Income | 87 | 97 | 108 | 133 | 137 | |
Total Expenditure | -78 | -91 | -106 | -117 | -128 | |
PBIDT | 9 | 6 | 2 | 16 | 9 | |
Interest | 0 | 0 | 0 | 0 | -2 | |
Depreciation | -1 | -2 | -3 | -4 | -10 | |
Taxation | -2 | -1 | 0 | -4 | -2 | |
Exceptional Items | 1 | |||||
PAT | 6 | 3 | 0 | 9 | -4 | |
Minority Interest | ||||||
Share Associate | ||||||
Other Related Items | ||||||
Consolidated Net Profit | 6 | 3 | 0 | 9 | -4 | |
Adjusted EPS | 2 | 1 | 0 | 4 | -2 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -3 | 6 | -1 | 13 | |
Cash Fr. Inv. | 9 | -4 | 4 | -27 | |
Cash Fr. Finan. | -6 | -3 | -2 | 14 | |
Net Change | -1 | -1 | 1 | 1 | |
Cash & Cash Eqvt | 2 | 1 | 1 | 2 |
Thu, 25 May 2023
Board Meeting Intimation
|
|
Wed, 24 May 2023
Board Meeting Intimation
|
|
Thu, 11 May 2023
Loss of Share Certificates
|
Fri, 26 May 2023 |
|
|
|
|
|